(P-43) A Single Composite Peptide Vaccine Comprising Conserved Influenza Epitopes Formulated with ALFQ Adjuvant Induced Broadly Reactive Antibodies to Human, Avian, and Swine Influenza Viruses

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Clara J. Sei, MPH (she/her/hers)

Vice President, Vaccine and Antibody Development
Longhorn Vaccines & Diagnostics, LLC
Gaithersburg, Maryland, United States
MR

Mangala Rao, n/a

Military HIV Research Program
Silver Spring, Maryland, United States
KK

Kellie Kroscher, PhD

Longhorn Vaccines & Diagnostics, LLC
Gaithersburg, Maryland, United States
GM

Gary Matyas, PhD

Military HIV Research Program
Silver Spring, Maryland, United States
RS

Richard F Schuman, PhD

Antibody and Immunoassay Consultants
Rockville, Maryland, United States
KM

Kevin Muema, BS

Research Associate
Longhorn Vaccines & Diagnostics, LLC
Gaithersburg, Maryland, United States
CL

Camille Lange, PhD

Henry M Jackson Foundation for the Advancement of Military Medicine
Bethesda, Maryland, United States
AA

Aba Assiaw-Dufu, BS

Longhorn Vaccines & Diagnostics, LLC
Gaithersburg, Maryland, United States
CA

Carl R. Alving, MD

Walter Reed Army Institute of Research
Silver Spring, Maryland, United States
GF

Gerald W. Fischer, MD

Chairman and Chief Executive Officer
Longhorn Vaccines & Diagnostics, LLC
Bethesda, Maryland, United States